Publication | Open Access

Eltrombopag versus placebo for low-risk myelodysplastic syndromes with thrombocytopenia (EQoL-MDS): phase 1 results of a single-blind, randomised, controlled, phase 2 superiority trial

Eltrombopag Versus PlaceboThrombosisThrombopoiesisHematological MalignancySuperiority TrialVenous ThrombosisHematologyMedicineAnticoagulantPhase 1